Suppr超能文献

解脲脲原体 3 血清型慢性羊膜内感染/定植后的多带抗原大小变异。

Ureaplasma parvum serovar 3 multiple banded antigen size variation after chronic intra-amniotic infection/colonization.

机构信息

Institute of Health & Biomedical Innovation, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.

出版信息

PLoS One. 2013 Apr 26;8(4):e62746. doi: 10.1371/journal.pone.0062746. Print 2013.

Abstract

Ureaplasma species are the microorganisms most frequently associated with adverse pregnancy outcomes. The multiple banded antigen (MBA), a surface-exposed lipoprotein, is a key virulence factor of ureaplasmas. The MBA demonstrates size variation, which we have shown previously to be correlated with the severity of chorioamnion inflammation. We aimed to investigate U. parvum serovar 3 pathogenesis in vivo, using a sheep model, by investigating: MBA variation after long term (chronic) and short term (acute) durations of in utero ureaplasma infections, and the severity of chorioamnionitis and inflammation in other fetal tissues. Inocula of 2 × 10(7) colony-forming-units (CFU) of U. parvum serovar 3 (Up) or media controls (C) were injected intra-amniotically into pregnant ewes at one of three time points: day 55 (69d Up, n = 8; C69, n = 4); day 117 (7d Up, n = 8; C7, n = 2); and day 121 (3d Up, n = 8; C3, n = 2) of gestation (term = 145-150d). At day 124, preterm fetuses were delivered surgically. Samples of chorioamnion, fetal lung, and umbilical cord were: (i) snap frozen for subsequent ureaplasma culture, and (ii) fixed, embedded, sectioned and stained by haematoxylin and eosin stain for histological analysis. Selected fetal lung clinical ureaplasma isolates were cloned and filtered to obtain cultures from a single CFU. Passage 1 and clone 2 ureaplasma cultures were tested by western blot to demonstrate MBA variation. In acute durations of ureaplasma infection no MBA variants (3d Up) or very few MBA variants (7d Up) were present when compared to the original inoculum. However, numerous MBA size variants were generated in vivo (alike within contiguous tissues, amniotic fluid and fetal lung, but different variants were present within chorioamnion), during chronic, 69d exposure to ureaplasma infection. For the first time we have shown that the degree of ureaplasma MBA variation in vivo increased with the duration of gestation.

摘要

脲原体属物种是与不良妊娠结局最相关的微生物。多带抗原 (MBA) 是一种表面暴露的脂蛋白,是脲原体属的关键毒力因子。MBA 表现出大小变异,我们之前已经证明这种变异与绒毛膜羊膜炎的严重程度相关。我们旨在通过羊模型研究解脲脲原体血清型 3 的发病机制,通过研究以下内容:宫内脲原体感染的长期(慢性)和短期(急性)持续时间后 MBA 的变化,以及绒毛膜羊膜炎和其他胎儿组织炎症的严重程度。将 2×10(7)个集落形成单位 (CFU) 的解脲脲原体血清型 3 (Up) 或培养基对照 (C) 接种物分别在妊娠母羊的三个时间点之一注入羊膜腔:第 55 天(69d Up,n = 8;C69,n = 4);第 117 天(7d Up,n = 8;C7,n = 2);和第 121 天(3d Up,n = 8;C3,n = 2)妊娠(足月 = 145-150 天)。在第 124 天,通过手术分娩早产胎儿。采集绒毛膜羊膜、胎儿肺和脐带样本:(i)立即冷冻,用于随后的脲原体培养,和(ii)固定、嵌入、切片和用苏木精和伊红染色进行组织学分析。选择的胎儿肺临床脲原体分离株进行克隆和过滤,以从单个 CFU 获得培养物。第 1 代和克隆 2 代脲原体培养物通过 Western blot 进行测试,以证明 MBA 变异。在急性脲原体感染持续时间内,与原始接种物相比,没有 MBA 变体(3d Up)或只有很少的 MBA 变体(7d Up)存在。然而,在慢性、69d 暴露于脲原体感染期间,体内产生了许多 MBA 大小变体(在连续组织、羊水和胎儿肺中一样,但绒毛膜羊膜炎中存在不同的变体)。我们首次表明,体内脲原体 MBA 变异的程度随着妊娠时间的延长而增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2c6/3637154/856eada9e078/pone.0062746.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验